#35Growth Hormone & Body Composition
Hexarelin acetate
ghrelin/growth-hormone-secretagogue receptor agonist
Evidence: other human studyReviewed 2026-07-25
Investigated uses
- No adequately documented human investigated use for the exact catalog identity/formulation was identified; any vendor-promoted goals were excluded from evidence grading.
Mechanism and hypotheses
- Hexarelin is a synthetic ghrelin/growth-hormone-secretagogue receptor agonist studied in humans for endocrine and cardiovascular effects.
- Hypothesized: Performance and recovery uses are not approved and lack gray-vial equivalence data.
Human evidence
- No qualifying controlled human efficacy study for the exact catalog identity/formulation was identified in this review. Limitations: This is a bounded search conclusion, not proof that no report exists; identity, language and indexing limitations may apply.
Safety highlights
- Unknown or insufficiently characterized for the exact catalog product.
- Identity, purity, sterility, endotoxin, aggregation, immunogenicity, concentration and route-specific risks are not adequately characterized.
Regulatory context
No FDA-approved product matching the exact catalog presentation was identified in this review.
Sources used for this entry
- Growth hormone-releasing peptide human trial search — PubMed
- PubMed search: Hexarelin acetate — PubMed
- Drugs@FDA database — U.S. Food and Drug Administration
- EMA medicines search — European Medicines Agency